ID   Y1-Cyc-102
AC   CVCL_5G16
SY   Cyc-102; Cyc 102
DR   Wikidata; Q54995177
RX   PubMed=221910;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI:64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
RX   PubMed=221910; DOI=10.1073/pnas.76.4.1896;
RA   Rae P.A., Gutmann N.S., Tsao J., Schimmer B.P.;
RT   "Mutations in cyclic AMP-dependent protein kinase and corticotropin
RT   (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 76:1896-1900(1979).
//
RX   PubMed=6270152; DOI=10.1016/S0021-9258(19)68600-X;
RA   Watt V.M., Schimmer B.P.;
RT   "Association of a 68,000-dalton protein with adrenocorticotropin-sensitive
RT   adenylate cyclase activity in Y1 adrenocortical tumor cells.";
RL   J. Biol. Chem. 256:11365-11371(1981).
//